Search results
Precigen (PGEN) to Release Quarterly Earnings on Tuesday
ETF DAILY NEWS· 1 day agoPrecigen (NASDAQ:PGEN – Get Free Report) is scheduled to release its earnings data after the market closes on Tuesday, May 14th. Analysts expect Precigen to post earnings of ($0.09) per share ...
Innovent Receives NMPA Breakthrough Therapy Designation for IBI343(Anti-Claudin18.2 ADC)as...
Fort Wayne Journal Gazette· 7 days agoThe ...
R.I. health care spending skyrocketed after COVID. Now it’s coming back down to Earth.
Rhode Island Current via Yahoo News· 5 hours agoChalk it up to a post-pandemic comedown. The nearly $9 billion price tag associated with health care...
FDA advisers to weigh first psychedelic therapy in early June
FierceBiotech· 6 days agoLykos Therapeutics’ MDMA-assisted therapy is charting yet another first in the psychedelic field: an...
1 No-Brainer Growth Stock to Buy and Hold
Motley Fool via Yahoo Finance· 2 days agoThen there is donanemab, Eli Lilly's potential therapy for Alzheimer's disease (AD) that the FDA is currently considering. An approval here could jolt...
What Triggers Asthma?
Health via Yahoo News· 4 days agoYour healthcare provider is a good resource to go to for advice on how to improve this habit. They can help you manage withdrawal symptoms and recommend...
Q1 2024 Inspire Medical Systems Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 5 days agoTherefore, with the headline results of the SURMONT-OSA trial, we believe many of the...in their lateral wall [collapse], which would allow them to qualify for Inspire. We look forward to < ...
International Booker prize 2024: six expert reviews of the shortlisted books
The Conversation· 10 hours agoFrom a longlist of 12, six novels have been shortlisted for the 2023 International Booker prize. In Not a River, the final instalment in Selva Almada’s “trilogy of men”, past and present collide ...
Inogen (NASDAQ:INGN) Earns Hold Rating from Needham & Company LLC
ETF DAILY NEWS· 2 days agoNeedham & Company LLC reissued their hold rating on shares of Inogen (NASDAQ:INGN – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports ...
bluebird bio reports first commercial gene therapy use By Investing.com
Investing.com· 7 days agoThis development marks a major step in making the treatment accessible to patients with a history of...